Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world by Irma Convertino, Luciane Cruz Lopes, Nicole Pratt, Ylenia Ingrasciotta, Marco Tuccori

Get full text

SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study by Laura Augusta Gonella, Francesca Moretti, Annalisa Capuano, Caterina De Sarro, Lorenza Ferrara, Elisabetta Geninatti, Greta Guarnieri, Xhikjana Hysolakoj, Margherita Lalli, Olivia Leoni, Antea Maria Pia Mangano, Patrizia Marani Toro, Viviana Mecchia, Maria Caterina Merlano, Caterina Palleria, Anna Maria Potenza, Paola Rossi, Marco Rossi, Francesca Sanità, Ester Sapigni, Cristina Scavone, Claudia Sommaro, Marco Tuccori, Giovanna Zanoni, Ugo Moretti, VigiVax Working Group

Get full text

Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project by Chiara Bellitto, Ylenia Ingrasciotta, Federica Soardo, Andrea Spini, Luca L’Abbate, Giorgia Pellegrini, Clément Mathieu, Massimo Carollo, Marco Tuccori, Olivia Leoni, Arianna Mazzone, Domenica Ancona, Paolo Stella, Anna Cavazzana, Angela Scapin, Sara Lopes, Valeria Belleudi, Stefano Ledda, Paolo Carta, Paola Rossi, Lucian Ejlli, Ester Sapigni, Aurora Puccini, Rita Francesca Scarpelli, Giovambattista De Sarro, Rosa Gini, Alessandra Allotta, Sebastiano Addario Pollina, Giampaolo Bucaneve, Antea Maria Pia Mangano, Francesco Balducci, Carla Sorrentino, Ilenia Senesi, Ugo Trama, Francesca Futura Bernardi, Roberto Da Cas, Giorgio Costa, Silvana Anna Maria Urru, Annalisa Campomori, Stefania Spila Alegiani, Marco Massari, Romina Gallizzi, Gianluca Trifirò

Get full text